Core Insights - The latest shareholder equity disclosures for companies including Stone Four Pharmaceutical Group, Cornerstone Pharmaceuticals-B, and Huilyang Technology were made on September 26, 2025 [1] Group 1: Stone Four Pharmaceutical Group (02005) - China Pharmaceutical increased its holdings from 884 million shares to 885 million shares, representing a holding percentage change from 29.95% to 29.99% [2] - Qu Jiguang raised his stake from 1.204 billion shares to 1.205 billion shares, with a holding percentage change from 40.78% to 40.82% [2] Group 2: Cornerstone Pharmaceuticals-B (02616) - Yang Jianxin increased his holdings from 70.0927 million shares to 70.2427 million shares, with a holding percentage change from 4.75% to 4.76% [2] Group 3: Huilyang Technology (01860) - Song Xiaofei reduced his holdings from 2.1924 million shares to 2.0004 million shares, with a holding percentage change from 0.14% to 0.13% [2]
智通港股股东权益披露|9月26日